FHC
PTCT icon

First Horizon Corporation’s PTC Therapeutics PTCT Stock Holding History

First Horizon Corporation’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3K Hold
653
– – ﹤0.01% 675
2026
Q1 		$44.5K Sell
653
-41
-6% -$2.9K ﹤0.01% 656
2025
Q4 		$52.7K Buy
+694
New +$50.4K ﹤0.01% 651

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

First Horizon Corporation's PTCT Position: Q2 2026 in Review

First Horizon Corporation held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 653 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #675.

First Horizon Corporation first reported a position in PTCT in Q4 2025 and has held it in 3 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • First Horizon Corporation held 653 shares of PTC Therapeutics worth $53.3K as of Q2 2026.
  • First Horizon Corporation left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #675 holding.
  • First Horizon Corporation first reported a position in PTC Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.